Matches in Nanopublications for { ?s ?p "[The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_assertion description "[The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650937.RAyCqQEly9oRXRI_paBbL4Uumd1qETLCbBl9nNk8PL6fE130_provenance.
- NP901171.RApOFTh-0cTagY2t6T7lz0GCpyCWMMZME-GAtzK_lPxc8130_assertion description "[The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP901171.RApOFTh-0cTagY2t6T7lz0GCpyCWMMZME-GAtzK_lPxc8130_provenance.